↓ Skip to main content

Dove Medical Press

Article Metrics

Recent developments in age-related macular degeneration: a review

Overview of attention for article published in Clinical Interventions in Aging, August 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
2 tweeters
patent
3 patents
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
222 Dimensions

Readers on

mendeley
554 Mendeley
Title
Recent developments in age-related macular degeneration: a review
Published in
Clinical Interventions in Aging, August 2017
DOI 10.2147/cia.s143508
Pubmed ID
Authors

Waseem Al-Zamil, Sanaa Yassin

Abstract

Visual impairment in elderly people is a considerable health problem that significantly affects quality of life of millions worldwide. The magnitude of this issue is becoming more evident with an aging population and an increasing number of older individuals. The objective of this article was to review the clinical and pathological aspects of age-related macular degeneration (AMD), diagnostic tools, and therapeutic modalities presently available or underway for both atrophic and wet forms of the disease. An online review of the PubMed database was performed, searching for the key words. The search was limited to articles published since 1980 to date. Several risk factors have been linked to AMD, such as age (>60 years), lifestyle (smoking and diet), and family history. Although the pathogenesis of AMD remains unclear, genetic factors have been implicated in the condition. Treatment for atrophic AMD is mainly close observation, coupled with nutritional supplements such as zinc and antioxidants, whereas treatment of wet AMD is based on targeting choroidal neovascular membranes. Identification of modifiable risk factors would improve the possibilities of preventing the progression of AMD. The role of anti-vascular endothelial growth factor (anti-VEGF) agents has transformed the therapeutic approach of the potentially blinding disease "wet AMD" into a more favorable outcome.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 554 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 554 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 107 19%
Student > Ph. D. Student 66 12%
Student > Master 58 10%
Researcher 43 8%
Student > Doctoral Student 36 6%
Other 50 9%
Unknown 194 35%
Readers by discipline Count As %
Medicine and Dentistry 115 21%
Biochemistry, Genetics and Molecular Biology 80 14%
Nursing and Health Professions 29 5%
Pharmacology, Toxicology and Pharmaceutical Science 28 5%
Neuroscience 21 4%
Other 69 12%
Unknown 212 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#2,144,717
of 22,497,510 outputs
Outputs from Clinical Interventions in Aging
#231
of 1,815 outputs
Outputs of similar age
#41,055
of 291,465 outputs
Outputs of similar age from Clinical Interventions in Aging
#7
of 31 outputs
Altmetric has tracked 22,497,510 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,815 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.